Power of Story
Send a Tweet        
- Advertisement -

Share on Google Plus 1 Share on Twitter Share on Facebook 1 Share on LinkedIn Share on PInterest Share on Fark! Share on Reddit Share on StumbleUpon Tell A Friend (2 Shares)  

Printer Friendly Page Save As Favorite View Favorites (# of views)   3 comments

Brief rapamycin therapy in middle-aged mice extends lives

Quicklink submitted By   Follow Me on Twitter     Message Scott Baker     Permalink
Related Topic(s): ; , Add Tags

Well Said 1   News 1   Interesting 1  
View Ratings | Rate It

opednews.com Headlined to H4 8/26/16

Become a Fan
  (81 fans)
Elife - Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice.
Elife - Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice.
(Image by Next Big Future)
  Permission   Details   DMCA

In mice, the drug rapamycin is known to extend lives and delay some age-related problems. Questions remain about about how it promotes healthy aging, when, how much and how long to administer rapamycin, and how to avoid serious side effects. A new study showed brief therapy during middle age with rapamycin dramatically extended mouse lives. Findings revealed the need to further examine how gender and dose influence side effects and the drug's impact on susceptibility to and protection from different types of cancer.

Read the rest of the story HERE:

At www.eurekalert.org

- Advertisement -
- Advertisement -